Purchase Order 75F40125P00137
Award Date
7/24/25
Potential Completion Date
1/24/27
Potential Value
$96K
Federal Agency
Food and Drug Administration
Awardee
University Of Waterloo
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) has awarded a $161,602.00 firm fixed price purchase order to the University of Waterloo in Ottawa, Canada for the International Cannabis Policy Study (ICPS) Data Analysis. The University of Waterloo is an educational and research institution that frequently collaborates with U.S. federal agencies through both prime contracts and subcontracts, leveraging expertise in areas like data analytics, engineering, and...
This is a $1,215,324.40 Firm Fixed Price Delivery Order issued by the Food and Drug Administration (FDA) to Labstat International Inc., a leading analytical testing laboratory in Kitchener, Ontario. The contract is for Tobacco Lab Analysis Services and is part of a larger $45 million Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Labstat to provide laboratory services in support of the FDA's regulatory oversight of tobacco products. The contract covers a range of technical...
This is a $1,303,695.00 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA) to Central State University, a historically black university in Wilberforce, Ohio. The contract is for the "Characterization of Chemical Constituents from Smokable Hemp Flower and E-Cigarette" and was awarded under the FDA's Broad Agency Announcement (BAA) for regulatory science and innovation research. The work will be performed in Wilberforce, Ohio and is not set aside for...
This is a $467,253.90 firm fixed price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Labstat International Inc., a foreign-owned, for-profit organization. The contract is for the "Analysis of Matrix Specific HPHCS", which refers to the analysis of toxic constituents in tobacco, e-cigarette, cannabis, and CBD products to support the FDA's regulatory oversight. Labstat has been awarded multiple prior contracts by the...
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Labstat International Inc., a for-profit limited liability company based in Canada. The $619,328.55 contract is for the chemical and physical characterization of pod and disposable e-cigarette aerosol. This order is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract held by Labstat...
This federal contract award was issued by the Uniformed Services University of the Health Sciences, a defense agency, to the University of Guelph, a comprehensive public research university located in Guelph, Ontario, Canada. The $26,400.00 firm-fixed-price purchase order contract is for fatty acid analysis services. The contract is not designated as a set-aside. The University of Guelph has previously received federal contracts and grants from various U.S. government agencies, including the...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,122,157.92 firm fixed price delivery order contract to Labstat International Inc., a foreign-owned for-profit organization, to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products. This contract is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Labstat to provide tobacco laboratory services...
The Food and Drug Administration (FDA) awarded a $754,024.73 firm-fixed-price contract to S-3 Research LLC, a minority-owned, self-certified small disadvantaged business, to acquire data and services to better understand consumers and potential health risks from cannabis-derived products (CDPs). The contract, which does not have a set-aside designation, has a completion date of February 12, 2027. S-3 Research is a data science company that provides research-as-a-service solutions to federal...
This is a firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Westat, Inc., a prominent professional services firm, for a CBD (cannabidiol) interviews research study. The contract has a ceiling value of $49,959.00 and a period of performance ending on February 28, 2024. The contract is a Blanket Purchase Agreement (BPA) call, which is a type of indefinite delivery vehicle (IDV) that allows the government to issue task orders for specific projects as needed. Westat...
This is a Firm Fixed Price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency within the Department of Health and Human Services, to Schauer, Gillian L, a sole proprietorship registered as a Woman Owned Business and Other Not For Profit Organization. The contract, awarded on December 3, 2019, is for $95,985.00 to provide "planning, management and technical support for CDC staff in the conduct of marijuana and public health activities...